Cargando…
Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic implications
Introduction: We compared the secretome of metastatic (non-small cell lung cancer (NSCLC)) and primary (mesothelioma) malignant pleural effusions, benign effusions and the published plasma profile of patients receiving chimeric antigen receptor T cells (CAR-T), to determine factors unique to neoplas...
Autores principales: | Donnenberg, Albert D., Luketich, James D., Donnenberg, Vera S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849644/ https://www.ncbi.nlm.nih.gov/pubmed/31741710 http://dx.doi.org/10.18632/oncotarget.27290 |
Ejemplares similares
-
Treatment of malignant pleural effusions: the case for localized immunotherapy
por: Donnenberg, Albert D., et al.
Publicado: (2019) -
KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients
por: Donnenberg, Albert D., et al.
Publicado: (2012) -
A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells
por: Donnenberg, Vera S., et al.
Publicado: (2023) -
Localized Intra-Cavitary Therapy to Drive Systemic Anti-Tumor Immunity
por: Donnenberg, Vera S., et al.
Publicado: (2022) -
Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)